Cargando…
Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma
BACKGROUND: To evaluate the feasibility of predicting tumor recurrence of hepatocellular carcinoma (HCC) patients after curative hepatectomy by detection of circulating tumor DNA (ctDNA) through droplet digital PCR (ddPCR). METHODS: HCC patients receiving surgical treatment were enrolled and periphe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154404/ https://www.ncbi.nlm.nih.gov/pubmed/32309384 http://dx.doi.org/10.21037/atm.2019.12.154 |
_version_ | 1783521809508859904 |
---|---|
author | Wang, Jian Huang, Ao Wang, Yu-Peng Yin, Yue Fu, Pei-Yao Zhang, Xin Zhou, Jian |
author_facet | Wang, Jian Huang, Ao Wang, Yu-Peng Yin, Yue Fu, Pei-Yao Zhang, Xin Zhou, Jian |
author_sort | Wang, Jian |
collection | PubMed |
description | BACKGROUND: To evaluate the feasibility of predicting tumor recurrence of hepatocellular carcinoma (HCC) patients after curative hepatectomy by detection of circulating tumor DNA (ctDNA) through droplet digital PCR (ddPCR). METHODS: HCC patients receiving surgical treatment were enrolled and peripheral blood samples before and after hepatectomy were collected. Four hotspot mutants, TP53-rs28934571 (c.747G>T), TRET-rs1242535815 (c.1-124C>T), CTNNB1-rs121913412 (c.121A>G) and CTNNB1-rs121913407 (c.133T>C) were selected to detect ctDNA and the mutant allele frequency (MAF) was calculated accordingly. The matched peripheral blood mononuclear cells (PBMCs) were used for Sanger sequencing. The clinicopathologic information of the patients was retrospectively analyzed and the predictive abilities for postoperative recurrence of different clinicopathologic parameters and ctDNA were compared. RESULTS: Eighty-one patients were enrolled and 70.4% (57/81) of them had detectable ctDNA before hepatectomy. Positive preoperative ctDNA status was related to larger tumor size (P=0.001), multiple tumor lesions (P=0.001), microvascular invasion (MVI) (P<0.001), advanced BCLC stages (P<0.001) and shorter disease free survival (DFS) (P<<0.001) and overall survival (OS) (P<<0.001). Multivariate analysis showed that detectable ctDNA was the independent risk factor for postoperative recurrence. Moreover, receiver operating characteristic (ROC) curves proved that ctDNA possessed the second largest area under the curve (AUC) in foretelling postoperative recurrence right after BCLC stage. For patients after surgery, the alterations of MAF were also correlated to postsurgical recurrence. Patients with increased MAF had more incidences of MVI (P=0.016) and recurrence (P<0.001). At the same time, Kaplan-Meier curves revealed a significant shorter DFS and OS in the patients with increased MAF compared to the patients with decreased MAF (P<0.001 and P=0.0045, respectively) and ROC curves showed MAF to possess the greatest AUC among all the indices for postoperative recurrence. CONCLUSIONS: Digital droplets PCR assessment of specific gene combination through ctDNA possesses potential prognostic value in HCC patients undergoing surgical treatment. |
format | Online Article Text |
id | pubmed-7154404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-71544042020-04-17 Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma Wang, Jian Huang, Ao Wang, Yu-Peng Yin, Yue Fu, Pei-Yao Zhang, Xin Zhou, Jian Ann Transl Med Original Article BACKGROUND: To evaluate the feasibility of predicting tumor recurrence of hepatocellular carcinoma (HCC) patients after curative hepatectomy by detection of circulating tumor DNA (ctDNA) through droplet digital PCR (ddPCR). METHODS: HCC patients receiving surgical treatment were enrolled and peripheral blood samples before and after hepatectomy were collected. Four hotspot mutants, TP53-rs28934571 (c.747G>T), TRET-rs1242535815 (c.1-124C>T), CTNNB1-rs121913412 (c.121A>G) and CTNNB1-rs121913407 (c.133T>C) were selected to detect ctDNA and the mutant allele frequency (MAF) was calculated accordingly. The matched peripheral blood mononuclear cells (PBMCs) were used for Sanger sequencing. The clinicopathologic information of the patients was retrospectively analyzed and the predictive abilities for postoperative recurrence of different clinicopathologic parameters and ctDNA were compared. RESULTS: Eighty-one patients were enrolled and 70.4% (57/81) of them had detectable ctDNA before hepatectomy. Positive preoperative ctDNA status was related to larger tumor size (P=0.001), multiple tumor lesions (P=0.001), microvascular invasion (MVI) (P<0.001), advanced BCLC stages (P<0.001) and shorter disease free survival (DFS) (P<<0.001) and overall survival (OS) (P<<0.001). Multivariate analysis showed that detectable ctDNA was the independent risk factor for postoperative recurrence. Moreover, receiver operating characteristic (ROC) curves proved that ctDNA possessed the second largest area under the curve (AUC) in foretelling postoperative recurrence right after BCLC stage. For patients after surgery, the alterations of MAF were also correlated to postsurgical recurrence. Patients with increased MAF had more incidences of MVI (P=0.016) and recurrence (P<0.001). At the same time, Kaplan-Meier curves revealed a significant shorter DFS and OS in the patients with increased MAF compared to the patients with decreased MAF (P<0.001 and P=0.0045, respectively) and ROC curves showed MAF to possess the greatest AUC among all the indices for postoperative recurrence. CONCLUSIONS: Digital droplets PCR assessment of specific gene combination through ctDNA possesses potential prognostic value in HCC patients undergoing surgical treatment. AME Publishing Company 2020-03 /pmc/articles/PMC7154404/ /pubmed/32309384 http://dx.doi.org/10.21037/atm.2019.12.154 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Wang, Jian Huang, Ao Wang, Yu-Peng Yin, Yue Fu, Pei-Yao Zhang, Xin Zhou, Jian Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma |
title | Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma |
title_full | Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma |
title_fullStr | Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma |
title_full_unstemmed | Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma |
title_short | Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma |
title_sort | circulating tumor dna correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154404/ https://www.ncbi.nlm.nih.gov/pubmed/32309384 http://dx.doi.org/10.21037/atm.2019.12.154 |
work_keys_str_mv | AT wangjian circulatingtumordnacorrelateswithmicrovascularinvasionandpredictstumorrecurrenceofhepatocellularcarcinoma AT huangao circulatingtumordnacorrelateswithmicrovascularinvasionandpredictstumorrecurrenceofhepatocellularcarcinoma AT wangyupeng circulatingtumordnacorrelateswithmicrovascularinvasionandpredictstumorrecurrenceofhepatocellularcarcinoma AT yinyue circulatingtumordnacorrelateswithmicrovascularinvasionandpredictstumorrecurrenceofhepatocellularcarcinoma AT fupeiyao circulatingtumordnacorrelateswithmicrovascularinvasionandpredictstumorrecurrenceofhepatocellularcarcinoma AT zhangxin circulatingtumordnacorrelateswithmicrovascularinvasionandpredictstumorrecurrenceofhepatocellularcarcinoma AT zhoujian circulatingtumordnacorrelateswithmicrovascularinvasionandpredictstumorrecurrenceofhepatocellularcarcinoma |